State Farm Mutual Automobile Insurance Co. Has $410,524,000 Holdings in Agilent Technologies, Inc. (A)

State Farm Mutual Automobile Insurance Co. continued to hold its stake in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 6,921,645 shares of the medical research company’s stock at the end of the 2nd quarter. State Farm Mutual Automobile Insurance Co. owned about 2.15% of Agilent Technologies worth $410,524,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of A. BlackRock Inc. lifted its stake in shares of Agilent Technologies by 1,946.9% in the first quarter. BlackRock Inc. now owns 23,119,219 shares of the medical research company’s stock valued at $1,222,310,000 after purchasing an additional 21,989,739 shares during the period. FMR LLC lifted its stake in shares of Agilent Technologies by 3.9% in the first quarter. FMR LLC now owns 21,588,407 shares of the medical research company’s stock valued at $1,141,379,000 after purchasing an additional 803,993 shares during the period. Vanguard Group Inc. lifted its stake in shares of Agilent Technologies by 0.4% in the first quarter. Vanguard Group Inc. now owns 21,455,971 shares of the medical research company’s stock valued at $1,134,378,000 after purchasing an additional 75,886 shares during the period. State Street Corp lifted its stake in shares of Agilent Technologies by 1.0% in the first quarter. State Street Corp now owns 14,457,425 shares of the medical research company’s stock valued at $764,348,000 after purchasing an additional 147,518 shares during the period. Finally, JPMorgan Chase & Co. lifted its stake in shares of Agilent Technologies by 45.2% in the second quarter. JPMorgan Chase & Co. now owns 12,145,610 shares of the medical research company’s stock valued at $720,358,000 after purchasing an additional 3,779,099 shares during the period.

Several analysts recently commented on A shares. Jefferies Group LLC reiterated a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research note on Wednesday, August 9th. Deutsche Bank AG reiterated a “buy” rating and issued a $66.00 price objective on shares of Agilent Technologies in a research note on Thursday, June 22nd. BidaskClub cut shares of Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. Barclays PLC restated a “buy” rating and set a $67.00 target price on shares of Agilent Technologies in a research report on Wednesday, July 19th. Finally, Morgan Stanley restated an “overweight” rating on shares of Agilent Technologies in a research report on Wednesday, August 16th. Three equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $63.91.

In related news, CEO Michael R. Mcmullen sold 16,492 shares of the firm’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $65.33, for a total transaction of $1,077,422.36. Following the transaction, the chief executive officer now owns 211,872 shares of the company’s stock, valued at $13,841,597.76. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Didier Hirsch sold 72,545 shares of the stock in a transaction that occurred on Tuesday, August 22nd. The shares were sold at an average price of $62.38, for a total value of $4,525,357.10. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 170,720 shares of company stock worth $10,795,039.

Shares of Agilent Technologies, Inc. (NYSE A) opened at 65.78 on Friday. The firm’s 50-day moving average is $62.75 and its 200 day moving average is $58.31. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $66.45. The stock has a market capitalization of $21.17 billion, a P/E ratio of 33.92 and a beta of 1.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Tuesday, August 15th. The medical research company reported $0.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.52 by $0.07. The business had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.49 earnings per share. On average, analysts expect that Agilent Technologies, Inc. will post $2.32 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 25th. Investors of record on Tuesday, October 3rd will be given a dividend of $0.132 per share. This represents a $0.53 annualized dividend and a yield of 0.80%. The ex-dividend date of this dividend is Monday, October 2nd. Agilent Technologies’s payout ratio is presently 27.32%.

TRADEMARK VIOLATION WARNING: “State Farm Mutual Automobile Insurance Co. Has $410,524,000 Holdings in Agilent Technologies, Inc. (A)” was published by BBNS and is the sole property of of BBNS. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://baseballnewssource.com/markets/state-farm-mutual-automobile-insurance-co-has-410524000-position-in-agilent-technologies-inc-a/1602641.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with our FREE daily email newsletter.

 


Latest News

American League Once Again Dominates National League
American League Once Again Dominates National League
Los Angeles Dodgers Waiting But Magic Number Down to One
Los Angeles Dodgers Waiting But Magic Number Down to One
Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22


Leave a Reply

 
© 2006-2017 BBNS.